ALNY vs BZH · P/E 76, rev $1.29B vs P/E 8.0, rev $2.37B
Alnylam Pharmaceuticals Inc (ALNY) versus Beazer Homes USA Inc (BZH) — a side-by-side from cached financials, not a winner call.
Alnylam Pharmaceuticals Inc (ALNY) is a biotechnology company listed on US.
Beazer Homes USA Inc (BZH) is a residential construction company listed on US.
Latest reported ALNY revenue for 2026-06-30 was $1.29B. Net income was $164.5M. Revenue was up 3.4% from 2025-09-30 to 2026-06-30. ALNY currently screens at market cap $40.46B and trailing P/E 76.3.
Latest reported BZH revenue for 2025-09-30 was $2.37B. Net income was $45.6M. BZH currently screens at market cap $746.7M and trailing P/E 8.0.
ALNY currently screens at market cap $40.46B and trailing P/E 76.3. BZH currently screens at market cap $746.7M and trailing P/E 8.0.
Not investment advice. Open the ALNY and BZH stock pages for the full models.
Not investment advice.